Literature DB >> 9187683

Differential stability of the (GAA)n tract in the Friedreich ataxia (STM7) gene.

C Epplen1, J T Epplen, G Frank, B Miterski, E J Santos, L Schöls.   

Abstract

Friedreich ataxia (FA) is an autosomal recessive, neurodegenerative disorder characterized by polypurine trinucleotide expansion. The (GAA)n motif is located in intron 18 of the STM7 gene (previously considered as intron 1 of the X25 gene) on chromosome 9q13. We studied the distribution profile of the polymorphic (GAA)n repetitive tract in 178 healthy individuals. The number of repeats of the trinucleotide block ranged from 7 to 29. In three individuals there were more than 29 repetitions of the GAA motif. While two of the individuals would be diagnosed as carriers of the FA mutation (GAA size > 90), the status of the third person, with a (GAA)58 tract, appears less clear at present. Thus an FA carrier rate of 1/60 to 1/90 can be assumed for the German population. In addition an intermediate-sized allele, (GAA)38 was identified in a mother with two affected children. The (GAA)38 allele appears to be expanded during transmission to at least (GAA)66 and (GAA) > 400 in her two FA-affected offspring. Therefore the shortest known STM7 allele conferring FA is (GAA)66. These novel facts have to be considered for differential diagnosis and definition of the FA carrier state.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9187683     DOI: 10.1007/s004390050458

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  27 in total

1.  New clues on the origin of the Friedreich ataxia expanded alleles from the analysis of new polymorphisms closely linked to the mutation.

Authors:  Antonella Monticelli; Manuela Giacchetti; Irene De Biase; Luigi Pianese; Mimmo Turano; Massimo Pandolfo; Sergio Cocozza
Journal:  Hum Genet       Date:  2004-02-07       Impact factor: 4.132

Review 2.  Friedreich ataxia: an overview.

Authors:  M B Delatycki; R Williamson; S M Forrest
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

3.  Cardiomyopathy of Friedreich's ataxia: use of mouse models to understand human disease and guide therapeutic development.

Authors:  R Mark Payne; P Melanie Pride; Clifford M Babbey
Journal:  Pediatr Cardiol       Date:  2011-03-01       Impact factor: 1.655

4.  A TAT-frataxin fusion protein increases lifespan and cardiac function in a conditional Friedreich's ataxia mouse model.

Authors:  Piyush M Vyas; Wendy J Tomamichel; P Melanie Pride; Clifford M Babbey; Qiujuan Wang; Jennifer Mercier; Elizabeth M Martin; R Mark Payne
Journal:  Hum Mol Genet       Date:  2011-11-23       Impact factor: 6.150

5.  Naturally extended CT . AG repeats increase H-DNA structures and promoter activity in the smooth muscle myosin light chain kinase gene.

Authors:  Yoo-Jeong Han; Primal de Lanerolle
Journal:  Mol Cell Biol       Date:  2007-11-08       Impact factor: 4.272

6.  Absence of aprataxin gene mutations in a Greek cohort with sporadic early onset ataxia and normal GAA triplets in frataxin gene.

Authors:  C Daiou; K Christodoulou; G Xiromerisiou; M Panas; E Dardiotis; A Kladi; M Speletas; G Ntaios; A Papadimitriou; A Germenis; Georgios M Hadjigeorgiou
Journal:  Neurol Sci       Date:  2009-12-02       Impact factor: 3.307

7.  Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management.

Authors:  M Anheim; M Fleury; B Monga; V Laugel; D Chaigne; G Rodier; E Ginglinger; C Boulay; S Courtois; N Drouot; M Fritsch; J P Delaunoy; D Stoppa-Lyonnet; C Tranchant; M Koenig
Journal:  Neurogenetics       Date:  2009-05-14       Impact factor: 2.660

8.  Length-dependent structure formation in Friedreich ataxia (GAA)n*(TTC)n repeats at neutral pH.

Authors:  V N Potaman; E A Oussatcheva; Y L Lyubchenko; L S Shlyakhtenko; S I Bidichandani; T Ashizawa; R R Sinden
Journal:  Nucleic Acids Res       Date:  2004-02-20       Impact factor: 16.971

9.  Autologous stem cell transplant with gene therapy for Friedreich ataxia.

Authors:  Naoki Tajiri; Meaghan Staples; Yuji Kaneko; Seung U Kim; Theresa A Zesiewicz; Cesar V Borlongan
Journal:  Med Hypotheses       Date:  2014-06-09       Impact factor: 1.538

10.  Alleviating GAA Repeat Induced Transcriptional Silencing of the Friedreich's Ataxia Gene During Somatic Cell Reprogramming.

Authors:  Urszula Polak; Yanjie Li; Jill Sergesketter Butler; Marek Napierala
Journal:  Stem Cells Dev       Date:  2016-10-17       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.